|search over 1,000 Venture Capital related sites|
|1.||Elderstreet Investments Ltd history (99%):|
Elderstreet was acquired by Dresdner Kleinwort Wasserstein ('DKW') in November 2000. In October 2003 the management purchased the business back from DKW. Elderstreet continues to manage a number of funds on behalf of DKW including its investment in Elderstreet Capital Partners. Copyright © Elde...
|2.||Harvest Partners (63%):|
We have approximately $1 billion under management. Our capital has historically come from major Western European financial institutions and industrial firms. In recent years, we have added significant capital from major U.S. institutions such as public and private pension funds, insurance companies ...
|3.||» Kennet Venture Partners (47%):|
FOR IMMEDIATE RELEASE CONSUL Risk Management secures an €11 million investment from Softbank Europe Ventures, along with Dresdner Kleinwort Wasserstein, NeSBIC CTe Fund and Kennet Capital Completes the second round of funding for the emerging leader in the security audit software market Novembe...
|4.||» Kennet Venture Partners (47%):|
FOR IMMEDIATE RELEASE CONSUL Risk Management secures an €11 million investment from Softbank Europe Ventures, along with Dresdner Kleinwort Wasserstein, NeSBIC CTe Fund and Kennet Capital completes the second round of funding for the emerging leader in the security audit software market Novembe...
|5.||Brantley Partners - Sources of Funds (41%):|
Brantley and its affiliates are comprised of several private equity partnerships and a public business development company. The private partnerships are comprised of a number of significant institutional investors including the following: Adams Street Partners BancBoston Capital Bank of America Bax...
|6.||Abingworth - News (35%):|
News Abingworth appoints Joe Anderson to manage quoted life science investments London, UK, 10 February 2004 - Abingworth Management, the international life science group, has appointed Dr Joe Anderson as manager of Abingworth s investments in quoted development stage biotechnology companies. He is ...
|7.||JMP Securities (32%):|
> Senior Management > News > Fact Sheet > Careers > Business Continuity > Contact Us Charles C. Duncan, Ph.D. Managing Director Senior Analyst, Biotechnology Charles Duncan joined JMP Securities LLC in November 2002 as a Managing Director and Senior Analyst covering biotechnology. ...
|8.||JMP Securities (32%):|
> Senior Management > News > Fact Sheet > Careers > Business Continuity > Contact Us Robert F. Carey Managing Director Healthcare Bob Carey joined JMP Securities LLC in January 2003 and is a Managing Director. Bob has a broad base of experience in the biotechnology, medical technol...
SpikeSource Raises $12.9M Series A For Open Source Certification By Jonathan Shieber 5/27/2005 SpikeSource, a provider of testing, certification, and management services for open source software, has raised $12.9 million in its Series A round of venture capital funding. The round was co-led by new i...
|10.||EVP - Management Profile (30%):|
MANAGEMENT PROFILES Ross Ahlgren Maurizio PetitBon Raoul Stein M rten Vading Malcolm Williams Geoffrey Wooley Ross Ahlgren Ross has been heavily involved with the development of EVP’s newer markets and focuses on sales and marketing across Europe. Ross Ahlgren has significant experience in op...
|11.||Ball, Simon (25%):|
3i's worldwide sites Search this site Countries... ------------------------ Asia Belgium Denmark Finland France Germany Italy Netherlands Spain Sweden Switzerland UK USA Home About 3i How we invest Our portfolio 3i publications Media centre Contacts You are here : Home > Contacts > Simon Ball ...
|12.||Geometry Group -- Our People (25%):|
The Management Team James W. Lewis Chairman The Chairman and founder of Geometry Group, Inc. is a former Managing Director of Morgan Stanley, where he held senior management positions in the asset management, equity, and fixed income areas for 17 years and served as Chairman of their Risk Managemen...
|13.||ARCIS - Team (25%):|
ARCIS GROUP TEAM INVESTMENTS Home Contacts French The ARCIS team has extensive private equity experience, having purchased positions in private equity funds as well as directly in portfolios of companies in Europe, the US and in Asia. Our team of professionals has developed strong relationships wit...
|14.||Advent International: IPOs (24%):|
Advent International has an outstanding track record of bringing companies to public markets. To date, over 130 of our portfolio companies have completed IPOs on 20 stock exchanges in North America, Europe, Asia and Latin America. We have also helped companies raise nearly $3bn in high-yield debt in...
|15.||Welcome to Coller Capital (23%):|
print page Dresdner Bank's Institutional Restructuring Unit sells US $90m North American private equity portfolio to Coller Capital Date: 16/09/04 The Institutional Restructuring Unit (IRU) of Dresdner Bank has reached an agreement with Coller Capital to sell a private equity portfolio consisting of...
|16.||Leadership team (21%):|
3i's worldwide sites Search this site Countries... ------------------------ Asia Belgium Denmark Finland France Germany Italy Netherlands Spain Sweden Switzerland UK USA Home About 3i How we invest Our portfolio 3i publications Media centre Contacts You are here : Home > About 3i > Leadership ...
|17.||ARCIS - l'Équipe (21%):|
GROUPE ARCIS EQUIPE INVESTISSEMENTS Accueil Contacts English L'équipe fondatrice d'ARCIS, pionnière du marché secondaire dans le "private equity" tant aux Etats-Unis depuis 1984, qu'en Europe depuis 1993, a développé une solide expertise assise sur plus ...
|18.||Medical Device Seed Capital - Medical Technology Incubator - AMV (19%):|
The Team The AMV team has significant executive management, operating and board experience, as well as demonstrated expertise in sourcing, financing and exiting successful medical device companies. They have collectively co-founded 15 companies, raised over $250 million in private equity capital an...
|19.||Lombard Investments - Private Equity Manager in North America and Asia (18%):|
Home Team Portfolio Media Contact » Managing Directors » Investment Professionals Lombard Team Investment Professionals Kanchit Bunajinda Anita Chik Surasak Khaoroptham Ratakorn Kiatikajornthada Christopher Lai Margaret Lee Geoffrey Lim Jean-Pierre Noel Nopadol Pipopsukhavadee Vincent Po...
|20.||Abingworth - UK Management Team (17%):|
UK Management Team Stephen Bunting, Managing Director has a PhD in Biological Sciences and has been in the venture capital business since 1983, specialising in the biotechnology and medical field. Before joining Abingworth in 1987, he worked for N M Rothschild & Sons as an advisor to Biotechnology I...